rs119480069
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 12P and 1B. PM1PM2PP5_Very_StrongBP4
The NM_022436.3(ABCG5):c.1166G>A(p.Arg389His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R389C) has been classified as Uncertain significance.
Frequency
Consequence
NM_022436.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCG5 | NM_022436.3 | c.1166G>A | p.Arg389His | missense_variant | 9/13 | ENST00000405322.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCG5 | ENST00000405322.8 | c.1166G>A | p.Arg389His | missense_variant | 9/13 | 1 | NM_022436.3 | P1 | |
ABCG5 | ENST00000486512.5 | n.1687G>A | non_coding_transcript_exon_variant | 5/9 | 1 | ||||
ABCG5 | ENST00000409962.1 | n.1449G>A | non_coding_transcript_exon_variant | 5/9 | 2 | ||||
ABCG5 | ENST00000644754.1 | n.1550G>A | non_coding_transcript_exon_variant | 6/10 |
Frequencies
GnomAD3 genomes ? AF: 0.0000986 AC: 15AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251474Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135914
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727244
GnomAD4 genome ? AF: 0.0000985 AC: 15AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74474
ClinVar
Submissions by phenotype
Sitosterolemia 2 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 19, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 30, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 28, 2021 | PS3, PS4, PM3 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Feb 08, 2022 | - - |
Sitosterolemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 08, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 389 of the ABCG5 protein (p.Arg389His). This variant is present in population databases (rs119480069, gnomAD 0.2%). This missense change has been observed in individual(s) with sitosterolemia (PMID: 11138003, 15375183, 20521169, 20543520, 25665839, 28203044, 28771437, 30985648, 31060161). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Asian ancestry (PMID: 15375183, 30985648). ClinVar contains an entry for this variant (Variation ID: 4980). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 22, 2023 | The p.R389H variant (also known as c.1166G>A), located in coding exon 9 of the ABCG5 gene, results from a G to A substitution at nucleotide position 1166. The arginine at codon 389 is replaced by histidine, an amino acid with highly similar properties. This variant has been reported in the homozygous and compound heterozygous states in several individuals and families affected with sitosterolemia, being reported as a common cause of disease in Asian populations (Lee MH et al. Nat Genet, 2001 Jan;27:79-83; Wang J et al. J Lipid Res, 2004 Dec;45:2361-7; Niu DM et al. J Inherit Metab Dis, 2010 Aug;33:437-43; Tada H et al. JIMD Rep, 2015 Feb;21:115-22; Ono S et al. Clin Pediatr Endocrinol, 2017 Jan;26:17-23; Yagasaki H et al. J Pediatr Endocrinol Metab, 2017 Aug;30:1007-1011; Huang D et al. Medicine (Baltimore), 2019 Apr;98:e15013; Nomura A et al. Circ Genom Precis Med, 2020 10;13:417-423; Yamada Y et al. CJC Open, 2021 Aug;3:1085-1088). An in vitro study suggested this alteration may impact protein function (Graf GA et al. J Biol Chem, 2004 Jun;279:24881-8). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at